Compare VNRX & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNRX | MRM |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 7.6M |
| IPO Year | 2012 | 2020 |
| Metric | VNRX | MRM |
|---|---|---|
| Price | $0.17 | $0.35 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.62 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 349.8K |
| Earning Date | 11-12-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,727,384.00 | N/A |
| Revenue This Year | $57.67 | N/A |
| Revenue Next Year | $240.52 | N/A |
| P/E Ratio | ★ N/A | $32.01 |
| Revenue Growth | ★ 40.04 | N/A |
| 52 Week Low | $0.13 | $0.25 |
| 52 Week High | $3.26 | $2.85 |
| Indicator | VNRX | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 22.79 | 20.66 |
| Support Level | $0.15 | N/A |
| Resistance Level | $0.18 | $1.31 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 0.32 | 23.12 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.